Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04904731 |
Other study ID # |
3658/20 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
February 19, 2021 |
Est. completion date |
May 24, 2021 |
Study information
Verified date |
May 2021 |
Source |
Azienda Ospedaliera di Perugia |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The present investigation aims to assess the diaphragmatic thickening fraction, reflecting
the diaphragmatic activity, during supine (baseline) and at 1 hour following prone position
in patients assisted through non invasive ventilation due to hypoxemic acute respiratory
failure related to COVID-19. Also, the impact of lung aeration and comfort were ascertained
in the same setting
Description:
Primary aim is to asses the effects of body position on diaphragmatic thickening fraction
(primary aim) and lung aeration and vital sign (secondary aims) in patents assisted via
noninvasive ventilation (NIV) for hypoxemic acute respiratory failure (hARF) associated to
COVID-19. All adult patients, admitted for hARF due to COVID-19 and requiring NIV were
enrolled.
Diaphragmatic thickening fraction, lung aeration assessed through ultrasound, comfort, and
grade of sedation-agitation as well as vital signs, i.e., peripheral oxygen saturation, blood
pressure, and breathing pattern were monitored during noninvasive ventilation in supine and
after 1 hour following the switch to prone position.